Compare Marriott International Inc (MAR) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Marriott International (MAR) trades at $365.88, up 2.63% with strong technical momentum and bullish moving averages. The company shows solid revenue growth to $26.19B in 2025 and consistent earnings beats, though valuation ratios remain elevated with a P/E of 37.38. Recent developments include strategic technology partnerships and dividend declarations, while institutional activity shows mixed positioning adjustments.

Outlook remains positive with analyst consensus target of $386.71 offering 5.7% upside potential. Key opportunities include travel recovery momentum and operational efficiency gains, while risks center on high debt levels (debt-to-asset ratio of 58.83%) and potential economic sensitivity. The stock presents a balanced risk-reward profile with moderate growth expectations.

Zimmer Biomet (ZBH) trades at $88.70, up 0.24% on the day, with a bearish technical outlook but strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $2.07 exceeding expectations. Revenue growth remains steady, reaching $8.23B in 2025, while profitability metrics like a 69.87% gross margin and 9.48% net margin reflect operational efficiency. Recent corporate news includes a $0.24 quarterly dividend declaration and leadership promotions aimed at accelerating commercial transformation.

The investment outlook is mixed, with analyst consensus leaning hold (52.38%) but a price target of $103.11 suggesting 16% upside. Key opportunities include sustained earnings beats and strategic initiatives, while risks involve rising debt levels, competitive pressures, and technical bearish signals. The stock's current valuation at a P/E of 21.57 appears reasonable relative to growth prospects, but investors should weigh fundamental strength against near-term technical weakness and macroeconomic headwinds in the healthcare sector.